Complement C5 inhibition in patients with COVID-19 - a promising target?
Régis Peffault de Latour, Anne Bergeron, Étienne Lengliné, Thibault Dupont, A. Marchal, Lionel Galicier, Nathalie De Castro, Louise Bondeelle, Michaël Darmon, Clairelyne Dupin, Guillaume Dumas, Pierre Leguen, Isabelle Madelaine, Sylvie Chevret, Jean‐Michel Molina, Élie Azoulay, Véronique Frémeaux‐Bacchi, CORE GROUP
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Complement (music)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyMedicineCoronavirus InfectionsComplement component 5Complement systemImmunologyInternal medicineBiologyAntibodyGeneticsInfectious disease (medical specialty)PhenotypeComplementationOutbreakDiseaseGeneSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesComplement system in diseases